Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

TranS1 to Distribute Spinal Devices in China through Beijing Jiade Sunshine

publication date: Oct 12, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
TranS1 Inc. of the US has struck a distribution deal with Beijing Jiade Sunshine for its spinal implants in mainland China. TranS1 makes minimally invasive products that treat degenerative spine conditions affecting the lower lumbar region. Included in the deal are the company’s AxiaLIF® devices, which are already registered with the SFDA. TranS1’s remaining instrumentation is expected to gain registration in Q4 of 2012. More details....

Stock Symbol: (NSDQ: TSON)

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Alibaba IPO
Event Updates
Greg Scott will be attending and speaking at this event:
 
 
Hope to see you there!
 
ChinaBio® Events
 
China Forum 2014

Frankfurt, Germany
November 2, 2014

>> More events...

Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors